Nazem Farzad

Nazem Farzad is listed in filings as Director at Nautilus Biotechnology, Inc.. This profile follows SEC Form 4 activity through Jun 25, 2025, including 2 public disclosures. Recent filings connect the profile to Nautilus Biotechnology, Inc. (NAUT). The current snapshot covers public activity from Jun 17, 2024 to Jun 25, 2025. Reported amounts are shown as $115.2K to $31.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.